141 related articles for article (PubMed ID: 12628523)
1. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.
Mehta RG; Hussain EA; Mehta RR; Das Gupta TK
Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy.
Hussain EA; Mehta RR; Ray R; Das Gupta TK; Mehta RG
Recent Results Cancer Res; 2003; 164():393-411. PubMed ID: 12899538
[TBL] [Abstract][Full Text] [Related]
3. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5.
Hussain-Hakimjee EA; Peng X; Mehta RR; Mehta RG
Carcinogenesis; 2006 Mar; 27(3):551-9. PubMed ID: 16195238
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.
Murillo G; Mehta RG
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):129-36. PubMed ID: 16051482
[TBL] [Abstract][Full Text] [Related]
6. Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5).
Mehta R; Hawthorne M; Uselding L; Albinescu D; Moriarty R; Christov K; Mehta R
J Natl Cancer Inst; 2000 Nov; 92(22):1836-40. PubMed ID: 11078761
[TBL] [Abstract][Full Text] [Related]
7. 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture.
Peng X; Hawthorne M; Vaishnav A; St-Arnaud R; Mehta RG
Breast Cancer Res Treat; 2009 Jan; 113(1):31-41. PubMed ID: 18205042
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5.
Mehta RG
Eur J Cancer; 2004 Oct; 40(15):2331-7. PubMed ID: 15454260
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of human breast carcinoma cells by a novel vitamin D analog: 1alpha-hydroxyvitamin D5.
Mehta RR; Bratescu L; Graves JM; Green A; Mehta RG
Int J Oncol; 2000 Jan; 16(1):65-73. PubMed ID: 10601550
[TBL] [Abstract][Full Text] [Related]
11. Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors.
Lazzaro G; Agadir A; Qing W; Poria M; Mehta RR; Moriarty RM; Das Gupta TK; Zhang XK; Mehta RG
Eur J Cancer; 2000 Apr; 36(6):780-6. PubMed ID: 10762752
[TBL] [Abstract][Full Text] [Related]
12. Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals.
Steele VE; Sharma S; Mehta R; Elmore E; Redpath L; Rudd C; Bagheri D; Sigman CC; Kelloff GJ
J Cell Biochem Suppl; 1996; 26():29-53. PubMed ID: 9154167
[TBL] [Abstract][Full Text] [Related]
13. Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells.
Peng X; Mehta R; Wang S; Chellappan S; Mehta RG
Cancer Res; 2006 Jul; 66(14):7361-9. PubMed ID: 16849588
[TBL] [Abstract][Full Text] [Related]
14. Regulation of steroid receptor expression by 1alpha-hydroxyvitamin D5 in hormone-responsive breast cancer cells.
Hussain-Hakimjee EA; Mehta RG
Anticancer Res; 2009 Sep; 29(9):3555-61. PubMed ID: 19667148
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of chemopreventive agents in mouse mammary gland organ culture (MMOC) model: a comprehensive review.
Mehta RG; Naithani R; Huma L; Hawthorne M; Moriarty RM; McCormick DL; Steele VE; Kopelovich L
Curr Med Chem; 2008; 15(27):2785-825. PubMed ID: 18991637
[TBL] [Abstract][Full Text] [Related]
17. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
18. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-3 receptor as a target for breast cancer prevention.
Welsh J; Wietzke JA; Zinser GM; Byrne B; Smith K; Narvaez CJ
J Nutr; 2003 Jul; 133(7 Suppl):2425S-2433S. PubMed ID: 12840219
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
